Paul Lock – Chairman & Managing Director – Pan Asia Metals (PAM) is a minerals exploration and development company with tungsten and lithium projects located in southern Thailand.
Copyright 2023 – Finance News Network
Source: Finance News Network
21 Mar 2021 - Elixinol Global (ASX:EXL) CEO, Oliver Horn talks about its proposed acquisition of CannaCare Health GmbH (CannaCare) one of Germany’s leading CBD (Cannabidiol) brands following the down scheduling of CBD in Europe late last year in what the Company sees as highly strategic opportunity and important pathway to profitability.
Read More08 Jul 2020 - Renergen Limited (ASX:RLT) Managing Director and CEO Stefano Marani talks about the company's high concentration of helium from Phase 1 drill results at its Virginia Gas Field in the Karoo Basin, South Africa.
Read More27 Jun 2023 - Chimeric Therapeutics Limited (ASX:CHM) CEO and Managing Director Jennifer Chow discusses promising results in the company's lead therapy for glioblastoma, and the timeline for the recently launched Phase 1b trial.
Read More01 Jun 2020 - OncoSil Medical Limited (ASX:OSL) Managing Director and CEO Daniel Kenny talks about the significance of the company's CE Marking approval for its lead product OncoSil, which helps treat pancreatic, liver and biliary duct cancer.
Read More12 Aug 2024 - Jindalee Lithium Limited (ASX:JLL) CEO Ian Rodger provides an overview of the company, discussing the McDermitt project, progress on the PFS and grant funding.
Read More05 Feb 2020 - Centuria Metropolitan REIT (ASX:CMA) Fund Manager, Grant Nichols talks 1H20 results, portfolio metrics and guidance.
Read More18 Apr 2024 - Anax Metals (ASX:ANX) CEO Geoff Laing discusses the company's innovative approach to mining as its pioneers bioleaching tech for sustainable resource extraction.
Read More27 Apr 2022 - Acorn Capital Investment Fund (ASX:ACQ) Portfolio Manager Rick Squire discusses key factors behind commodity demand and which commodities to keep an eye on.
Read More23 Sep 2019 - SUDA Pharmaceuticals Limited (ASX:SUD) Managing Director & CEO, Stephen Carter discusses the company's portfolio and the benefits of reformulating and delivering medication through the oral mucosa.
Read More10 Oct 2023 - Cameron Perks - Principal Analyst - Benchmark’s prices and data empowers clients: from critical mineral contracts to EV battery supply chain investments and government policy.
Read More
